In the pharmaceutical industry, quality is the lifeline. Pharmaceutical intermediates and active pharmaceutical ingredients (APIs), as the core materials in formulation manufacturing, directly determine the safety, efficacy, and stability of the final drug product. However, when faced with numerous suppliers both domestically and internationally, purchasers often encounter challenges such as information asymmetry and inconsistent product quality. So, how can you systematically evaluate and ensure the reliability of a supplier’s product quality during procurement? This article provides a detailed analysis from five key dimensions. 1. Strictly review supplier qualification documents

Qualification review is the “first hurdle” for screening qualified suppliers and must not be carried out in a perfunctory manner.

• Business License and Scope of Business: Verify that the supplier’s business license is genuine and valid, and that its scope of business explicitly covers the categories being procured.

Drug Production License and Registration Information: For active pharmaceutical ingredients and excipients, it is necessary to verify whether the supplier holds a valid drug production license and whether the relevant product has been registered on the CDE’s API‑Excipient‑Packaging Material Registration Platform, with a status of “A” (active) or “I” (inactive, requiring associated review).

Quality Management System Certification: Priority should be given to suppliers that have obtained internationally recognized quality management system certifications such as ISO 9001 and GMP. For export operations, it is also necessary to verify whether the company holds official certifications such as FDA or EDQM approval.

Specialized Permits: Where hazardous chemicals or precursor chemicals are involved, it is necessary to verify that the supplier holds the applicable hazardous chemical production or business license.

Hengyuehe Notice: Shanghai Hengyuehe Biopharmaceutical Co., Ltd. holds all necessary qualifications for pharmaceutical production, and its key product lines have been duly registered with the relevant authorities. Customers may review the company’s qualification documents at any time to conduct compliance checks.

2. Verify the Certificate of Analysis (COA) for each batch of products

The Certificate of Analysis (COA) serves as the “quality ID card” for each batch of products, and purchasers should make it a habit to verify it for every batch.

• Verify that the test items are complete: The COA should include key parameters such as appearance, identification, purity (assay), related substances (impurities), loss on drying, residue on ignition, residual solvents, and heavy metals, and the analytical methods should be in accordance with the current pharmacopoeial standards (e.g., CP, USP, EP, JP).
• Verification of Standards and Measured Values: In accordance with the agreed quality standards, verify each item to ensure that the batch’s measured values fall within the specified acceptance limits. Particular attention should be paid to changes in the impurity profile— even if the overall impurity level remains within specification, the emergence of a single new impurity may signal process variability.
• Verify the validity of the certification: The Certificate of Analysis (COA) must bear the signature or official stamp of an authorized representative from the supplier’s quality department and include information such as the batch number, date of manufacture, and expiration date.

Hengyuehe Note: Each batch of Hengyuehe products is accompanied by a complete Certificate of Analysis (COA). All tests are conducted by our fully equipped Quality Control Center, ensuring that the data is traceable, authentic, and reliable.

3. Conduct on-site quality audits of suppliers

Document reviews cannot replace field inspections. For critical material suppliers, a quality audit should be conducted, particularly prior to initial engagement or during periodic re-evaluations.

• Production Site and Facility Infrastructure: Conduct on-site inspections of the production workshops, warehouses, and utility systems (such as purified water and HVAC purification) to assess their operational status and determine whether the site’s management practices and physical infrastructure are in compliance with GMP requirements.

Quality Management System Operation: Evaluate whether the supplier’s quality management system is effectively implemented, including the soundness of processes such as deviation management, change control, complaint and recall handling, and internal audits.

Inspection Capability: Evaluate the supplier’s laboratory in terms of its instrument and equipment configuration, personnel qualifications, inspection operating procedures, and sample retention management.

Supplier Management: Assess whether the supplier’s management of its critical materials (starting materials, key reagents, etc.) is compliant with established procedures, ensuring that quality control can be traced back to the source.

Hengyuehe advises: Hengyuehe operates multiple GMP-compliant production facilities, and its quality management system has withstood continuous audits by both domestic and international customers. We welcome clients to conduct on-site audits and invite scrutiny of our operations, ensuring full transparency in everything we do.

4. Pay attention to batch stability and scalable production capacity

A qualified laboratory sample does not necessarily mean that large-scale commercial batches will be equally reliable. Process robustness and batch-to-batch consistency are key metrics for assessing a supplier’s capabilities.

• Request multi-batch sample testing: It is recommended to obtain at least three small batches for independent analysis, compare the variability of critical quality attributes across batches, and assess process robustness.
• Assess the history of scaled‑up production: Determine the number of batches the supplier has produced for this product, the maximum capacity per batch, and the total supply capacity. Suppliers with experience in large-scale, multi-batch production typically have more mature manufacturing processes.
• Pay attention to change management: Ask the supplier whether they have established rigorous change control procedures. Will any changes involving the manufacturing process, raw material sources, production facilities, or other related aspects be proactively communicated to customers in advance, with the requisite validation completed?

Hengyuehe advises: With more than a decade of expertise in the pharmaceutical intermediates and active pharmaceutical ingredient (API) fields, Hengyuehe boasts scalable production capabilities ranging from kilogram‑scale to ton‑scale, delivering highly consistent quality across batches to ensure seamless commercial manufacturing for our customers.

5. Assess supply chain stability and emergency response capabilities

Quality stability depends not only on the product itself but also on the continuity of supply. Material shortages could cause production lines to shut down, resulting in substantial losses.

• Raw material supply assurance: Assess whether the supplier’s procurement channels for key upstream raw materials are stable and whether there is a risk of over-reliance on a single source.

Procurement and Inventory Strategy: Ask suppliers whether they maintain a safety stock policy and whether their production capacity is flexible enough to handle customers’ urgent increases in demand.

Logistics and Delivery Records: Evaluate the supplier’s historical on-time order‑delivery rate, as well as its capabilities in logistics operations, such as temperature‑controlled transportation and hazardous‑materials shipping.

Hengyuehe advises: Hengyuehe maintains a robust supply-chain management system, holds appropriate safety stock levels, and has established long-term strategic partnerships with more than 120 renowned pharmaceutical companies both domestically and internationally, ensuring its sustained delivery capabilities have been thoroughly validated.

Ensuring the product quality of pharmaceutical intermediates and active pharmaceutical ingredients from suppliers is by no means as simple as “checking a COA”; it is a systematic undertaking. The purchaser shall integrate the five key processes of **qualification review, COA verification, on-site audits, batch‑to‑batch stability assessment, and supply chain assurance** into a cohesive, closed‑loop management system. Choosing a partner with comprehensive qualifications, proven quality, and a stable supply chain not only safeguards drug quality but also effectively mitigates compliance risks, laying a solid foundation for the company’s long-term development.

Shanghai Hengyuehe Biopharmaceutical Co., Ltd. is committed to delivering superior product quality and expert CDMO services, making us a long-term partner you can trust.